Join us for a focused session hosted by Pion and presented by Bend Bioscience exploring advanced analytical strategies to overcome complex formulation and performance challenges across oral, sublingual, and topical drug products.
In this webinar, you’ll gain practical insight into the development of a generic BCS Class IV oral suspension, including the use of multivariate design of experiments, real-time in situ dissolution monitoring, and Pion's microFLUX testing to establish in vitro–in vivo correlations and support reverse engineering of poorly permeable compounds.
We’ll also cover:
- Discriminatory dissolution methods for rapidly dissolving sublingual tablets (with release in under one minute)
- Formulation ranking strategies for ultra-fast release products
- Targeted in vitro release testing approaches for topical formulations aligned with clinical and regulatory expectations
Additionally, discover how an in situ fiber optic approach can transform IVRT by eliminating manual sampling, dilution, and media replacement. Learn how continuous, real-time monitoring can improve efficiency, reduce variability, and enhance accuracy, precision, and sensitivity.
Reserve your spot today.
